| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/15/2004 | CA2511625A1 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| 07/15/2004 | CA2511295A1 Methods for treating taxol-induced sensory neuropathy |
| 07/15/2004 | CA2511013A1 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 07/15/2004 | CA2510774A1 Amplified cancer target genes useful in diagnosis and therapeutic screening |
| 07/15/2004 | CA2510315A1 Antibodies against gpr64 and uses thereof |
| 07/15/2004 | CA2510314A1 Breast specific protein expressed in cancer and methods of use thereof |
| 07/15/2004 | CA2510309A1 Recombinant vaccine viruses expressing il-15 and methods of using the same |
| 07/15/2004 | CA2510173A1 Vaccine compositions and methods |
| 07/15/2004 | CA2509495A1 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents |
| 07/15/2004 | CA2509392A1 Methods of detecting the inhibition of fibrocyte formation and methods and compositions for enhancing fibrocyte formation |
| 07/15/2004 | CA2509241A1 Use of serum amyloid p (sap) and related compositions for the suppression of fibrosis-related diseases |
| 07/15/2004 | CA2508985A1 Branched immunomodulatory compounds and methods of using the same |
| 07/15/2004 | CA2508957A1 Yeast-based vaccines as immunotherapy |
| 07/15/2004 | CA2508592A1 High pressure spray-dry of bioactive materials |
| 07/15/2004 | CA2508209A1 Preparation and administration of hybrid cell vaccines for the prevention of cancer |
| 07/15/2004 | CA2485348A1 Dna vaccines against hantavirus infections |
| 07/14/2004 | EP1437400A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 07/14/2004 | EP1437364A2 Polypeptide binding to the androgen receptor and its potential use for treating breast cancer |
| 07/14/2004 | EP1436429A2 Targeted nucleic acid constructs and uses related thereto |
| 07/14/2004 | EP1436413A2 Response of dendritic cells to a diverse set of pathogens |
| 07/14/2004 | EP1436397A2 Hepatitis c virus vaccine |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436329A1 Anti-pdgf antibodies and methods for producing engineered antibodies |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436325A1 Microfluidized leishmania antigen and methods of making and using thereof |
| 07/14/2004 | EP1436323A1 Crystal structure of baff, and use thereof in drug design |
| 07/14/2004 | EP1436233A2 Metal binding proteins and associated methods |
| 07/14/2004 | EP1436004A1 Crustaceans as production systems for therapeutic proteins |
| 07/14/2004 | EP1436003A2 Taci-immunoglobulin fusion proteins |
| 07/14/2004 | EP1436002A1 Use of peptide vectors to improve the immune response to antigens |
| 07/14/2004 | EP1436001A1 Chicken anemia virus vaccine from cell line |
| 07/14/2004 | EP1436000A2 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists |
| 07/14/2004 | EP1435993A2 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/14/2004 | EP1435992A2 Chemokines as adjuvants of immune response |
| 07/14/2004 | EP1435987A1 Method and composition for treating immune complex associated disorders |
| 07/14/2004 | EP1435973A1 Coadministration of transport protein with conjugated cobalamin to deliver agents |
| 07/14/2004 | EP1435922A1 Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent |
| 07/14/2004 | EP1435905A1 Binary composition for "prime-boost" release of active ingredients like vaccines |
| 07/14/2004 | EP1435776A2 Anticancer vaccine and diganostic methods and reagents |
| 07/14/2004 | EP1372689B1 Use of ikk-beta inhibitors and method for discovery of said inhibitors |
| 07/14/2004 | EP0889907B1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH) |
| 07/14/2004 | CN1513058A Secretory streptococcus pneumoniae proteins |
| 07/14/2004 | CN1513000A Anti-osteopontin antibody and use thereof |
| 07/14/2004 | CN1512895A Use of polyclonal immunoglobulins |
| 07/14/2004 | CN1512894A Monocyte specific particulate delivery vehicle |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1511947A Gene expression preventing chronic transplanting rejection of recombined gland relative virus mediated haem oxidase-1 (HO-1) |
| 07/14/2004 | CN1511844A Pig pleuropneumonia actino bacillus gene engineering toxoid ApxI and dead bacterium mixed vaccine |
| 07/14/2004 | CN1511588A Japanese blood fluke nucleic acid vaccine |
| 07/14/2004 | CN1511587A Process for preparing Vero cell epidemic cold purified vaccine and its use |
| 07/13/2004 | US6762295 For the treatment or prevention of gastroduodenal disease associated heliobacter infections |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762179 (2-arylamino-4-thiazole)pyrimidine compounds; useful for treating diabetes, alzheimer's disease, stroke, proliferative disorders, and asthma |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762051 Methods of inhibiting helicobacter pylori |
| 07/13/2004 | US6762032 Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response |
| 07/13/2004 | US6762024 A polynucleic acid composition comprising of one polynucleic acid containing contiguous nucleotides corresponding to a nucleotide sequence from certain specific regions |
| 07/13/2004 | US6762020 Methods of diagnosing breast cancer |
| 07/13/2004 | US6761914 And an antigen that is preferably a recombinant fusion protein; from seeds from oilseed crops, such as soybean, rapeseed, sunflower and palm |
| 07/13/2004 | US6761901 Proliposomal compositions that are advantageously used to deliver biologically active compounds to the gastrointestinal tract after oral administration. |
| 07/13/2004 | US6761894 Immune response against intracellular pathogens and in particular mycobacterium tuberculosis. |
| 07/13/2004 | US6761893 Modified vaccinia ankara virus variant |
| 07/13/2004 | US6761892 Heat shock protein-based vaccines and immunotherapies |
| 07/13/2004 | US6761891 Medicament for treating a manifested lyme disease |
| 07/13/2004 | US6761890 Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine |
| 07/13/2004 | US6761889 Adjusting affinity of fab 27/26 fragments/polypeptides generating improved ragweed-induced histamine release inhibition; bronchodilator agents |
| 07/13/2004 | US6761888 Passive immunization treatment of Alzheimer's disease |
| 07/13/2004 | CA2288913C Membrane system for controlled tissue regeneration in cases of diseases of the peridontium |
| 07/13/2004 | CA2163212C Therapeutic compounds |
| 07/13/2004 | CA2131528C Methods and compositions for targeting the vasculature of solid tumors |
| 07/13/2004 | CA2118862C Bovine ovary cell line (frov) for virus replication |
| 07/08/2004 | WO2004056977A1 Production of alvac on avian embryonic stem cells |
| 07/08/2004 | WO2004056971A2 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 07/08/2004 | WO2004056869A1 Ghrelin receptor inverse agonist for regulation of feeding behaviours |
| 07/08/2004 | WO2004056862A2 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/08/2004 | WO2004056851A1 Peptides mimicking vibrio cholerae o139 capsular polysaccharide and their use to elicit protective immune response |
| 07/08/2004 | WO2004056392A1 Pharmaceutical compositions having an effect on the proliferation of nk cells and a method using the same |
| 07/08/2004 | WO2004056390A1 Trivalent vaccine with maternal antibody transfer via the milk |
| 07/08/2004 | WO2004056389A1 Hpv-16 and -18 l1 vlp vaccine |
| 07/08/2004 | WO2004056316A2 Vaccines against hiv-1 tat protein to generate neutralizing antibodies |
| 07/08/2004 | WO2004056312A2 Immunoglobulin variants and uses thereof |
| 07/08/2004 | WO2004056307A2 Disease treatment via antimicrobial peptide inhibitors |
| 07/08/2004 | WO2004041997A9 Immunotherapy regimens in hiv-infected patients |
| 07/08/2004 | WO2004034966A3 Substances for preventing and treating autoimmune diseases |
| 07/08/2004 | WO2004024909A3 Recombinant colstridium neurotoxin fragments |
| 07/08/2004 | WO2004019979A3 Vaccine comprising il-13 and an adjuvant |
| 07/08/2004 | WO2004019975A3 Il-14 vaccine for the treatment of asthma and atopic disorders |
| 07/08/2004 | WO2004019909A3 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| 07/08/2004 | WO2004019866A3 Compositions and methods for treating cardiovascular disease |
| 07/08/2004 | WO2004014322A3 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 07/08/2004 | WO2004014301A3 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 07/08/2004 | WO2004012657A3 Beta-glucan containing composites, methods for manufacturing and for using such composites |
| 07/08/2004 | WO2004009759A9 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 07/08/2004 | WO2004006853A3 Treatment and prophylaxis with 4-1bb-binding agents |
| 07/08/2004 | WO2004003143A3 Viruses and virus-like particles for multiple antigen and target display |
| 07/08/2004 | WO2003104259A3 PEPTIDES PRESENTED BY HLA-B18 AND Cw16 MOLECULES, AND USES THEREOF |
| 07/08/2004 | WO2003101399A3 Novel bacterium for treatment of disease |
| 07/08/2004 | WO2003097872A3 G - protein coupled receptor marker molecules associated with colorectal lesions |
| 07/08/2004 | WO2003090676A3 Immunogenic agent therapy using plasmapheresis or exchange transfusion |